G protein-coupled receptors in hypothalamic circuits involved in metabolic diseases

Current Opinion in Drug Discovery and Development

Volumn 7, Issue 5, 2004, Pages 665-682

  Bagnol, Didier ^a  

^a ARENA PHARMACEUTICALS   (United States)

Author keywords

Autonomic nervous system; Dorsal vagal complex; Eating disorders; Hypothalamus; Laser microdissection; Leptin; Melanocortin; Obesity; Olfactory receptors; Orphan receptors

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN;

BODY WEIGHT; CELLULAR DISTRIBUTION; EATING DISORDER; ENERGY BALANCE; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; HUMAN; HYPOTHALAMUS; METABOLIC DISORDER; NONHUMAN; OBESITY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION; HUMANS; HYPOTHALAMUS; METABOLIC DISEASES; MODELS, BIOLOGICAL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 4944227596     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. J Am Med Assoc (2003) 289(1):76-79.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States, 2000. J Am Med Assoc (2004) 291(10):1238-1245.
3. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol (2004) 24(2):e13-e18.
4. Vague J, Vague P, Tramoni M, Vialettes B, Mercier P: Obesity and diabetes. Acta Diabetol Lat (1980) 17(2):87-99.
5. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES: Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes (2004) 53(5):1195-1200.
6. Friedman JM: A war on obesity, not the obese. Science (2003) 299(5608):856-858.
7. Friedman JM: Obesity in the new millennium. Nature (2000) 404(6778):632-634.
8. Larsen PJ, Vrang N, Tang-Christensen M, Jensen PB, Hay-Schmidt A, Romer J, Bjerre-Knudsen L, Kristensen P: Ups and downs for neuropeptides in body weight homeostasis: Pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides. Eur J Pharmacol (2002) 440(2-3):159-172. A broad review on the control of energy balance that discusses the structural basis of the set-point or adipostat. The role of cocaine-amphetamine regulated transcript and pre-glucagon-derived peptides as satiating agents is also reviewed.
9. Stafford RS, Radley DC: National trends in antiobesity medication use. Arch Intern Med (2003) 163(9):1046-1050.
10. Drews J: Drug discovery: A historical perspective. Science (2000) 287(5460):1960-1964.
11. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE et al: Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 420(6915):520-562.
12. Chalmers DT, Behan DP: The use of constitutively active GPCRs in drug discovery and functional genomics. Nat Rev Drug Disc (2002) 1(8):599-608.
13. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB: The G protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol (2003) 63(6):1256-1272. An excellent analysis of the GPCR family.
14. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC, Bergmann JE et al: The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA (2003) 100(8):4903-4908.
15. Fredriksson R, Lagerstrom MC, Hoglund PJ, Schioth HB: Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions. FEBS Lett (2002) 531(3):407-414.
16. Kroeze WK, Sheffler DJ, Roth BL: G protein-coupled receptors at a glance. J Cell Sci (2003) 116(Pt 24):4867-4869.
17. Wise A, Jupe SC, Rees S: The identification of ligands at orphan G protein-coupled receptors. Annu Rev Pharmacol Toxicol (2004) 44:43-66. Review of GPCR deorphanization with a summary of the most recent discoveries.
18. Hur EM, Kim KT: G protein-coupled receptor signalling and crosstalk: Achieving rapidity and specificity. Cell Signal (2002) 14(5):397-405. This paper, along with references [19•], [20•] and [21•], provides an excellent in-depth analysis of GPCR signaling.
19. Marinissen MJ, Gutkind JS: G protein-coupled receptors and signaling networks: Emerging paradigms. Trends Pharmacol Sci (2001) 22(7):368-376. This paper, along with references [18•], [20•] and [21•], provides an excellent in-depth analysis of GPCR signaling.
20. Bockaert J, Marin P, Dumuis A, Fagni L: The 'magic tail' of G protein-coupled receptors: An anchorage for functional protein networks. FEBS Lett (2003) 546(1):65-72. This paper, along with references [18•], [19•] and [21•], provides an excellent in-depth analysis of GPCR signaling.
21. Rashid AJ, O'Dowd BF, George SR: Minireview: Diversity and complexity of signaling through peptidergic G protein-coupled receptors. Endocrinology (2004) 145(6):2645-2652. This paper, along with references [18•], [19•] and [20•], provides an excellent in-depth analysis of GPCR signaling.
22. Civelli O, Nothacker H, Saito Y, Wang Z, Lin SH, Reinscheid RK: Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci (2001) 24(4):230-237. Description of pioneering research and approaches to receptor deorphanization.
23. Thomsen WJ, Gatlin J, Unett DJ, Behan DP: Developing functional GPCR screens. Curr Drug Disc (2004) 4(1):13-18. A broad overview of assays available for current screening strategies. Advantages and inconveniences for developing functional screens are considered.
24. Lemer MR: Tools for investigating functional interactions between ligands and G protein-coupled receptors. Trends Neurosci (1994) 17(4):142-146.
25. Hetherington AW, Rao MS: Hypothalamic lesions and adiposity in the rat. Anat Rec (1940) 78:149-172.
26. Anand BK, Brobeck JR: Localization of a 'feeding center' in the hypothalamus of the rat. Proc Soc Exp Biol Med (1951) 77(2):323-324.
27. Keesey RE, Mitchel JS, Kemnitz JW: Body weight and body composition of male rats following hypothalamic lesions. Am J Physiol (1979) 237(1):R68-R73.
28. Levin BE, Routh VH: Role of the brain in energy balance and obesity. Am J Physiol (1996) 271(3 Pt 2):R491-R500. Discussion of brain pathways involved in the regulation of body weight.
29. Bellinger LL, Bernardis LL: The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: Lessons learned from lesioning studies. Physiol Behav (2002) 76(3):431-442.
30. Barsh GS, Schwartz MW: Genetic approaches to studying energy balance: Perception and integration. Nat Rev Genet (2002) 3(8):589-600. Recommended reading for anyone wishing to understand the neurobiology of energy balance.
31. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 372(6505):425-432.
32. Schwartz GJ, Moran TH: Leptin and neuropeptide Y have opposing modulatory effects on nucleus of the solitary tract neurophysiological responses to gastric loads: Implications for the control of food intake. Endocrinology (2002) 143(10):3779-3784.
33. Elmquist JK, Elias CF, Saper CB: From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron (1999) 22(2):221-232.
34. Considine RV: Weight regulation, leptin and growth hormone. Horm Res (1997) 48(Suppl 5):116-121.
35. Jequier E: Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci (2002) 967:379-388.
36. Wilson BD, Bagnol D, Kaelin CB, Ollmann MM, Gantz I, Watson SJ, Barsh GS: Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology (1999) 140(5):2387-2397.
37. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, Van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects. Nature (1997) 390(6658):349.
38. Ellacott KL, Cone RD: The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res (2004) 59:395-408. A detailed review on the implications of the melanocortin system in the regulation of food intake including a discussion on brain stem mechanisms.
39. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ et al: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell (1997) 88(1):131-141.
40. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by Agouti-related protein. Science (1997) 278(5335):135-138.
41. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL: Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev (1997) 11(5):593-602.
42. Clark JT, Kalra PS, Crowley WR, Kalra SP: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology (1984) 115(1):427-429.
43. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature (1996) 381(6581):415-421.
44. Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A et al: Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol (2002) 22(14):5027-5035.
45. Berthoud HR: Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev (2002) 26(4):393-428. An exhaustive review describing the CNS pathways and regions involved in feeding behavior and body weight regulation.
46. Flier JS: Obesity wars. Molecular progress confronts an expanding epidemic. Cell (2004) 116(2):337-350. An excellent review of molecular pathways involved in energy balance.
47. Seeley RJ, Woods SC: Monitoring of stored and available fuel by the CNS: Implications for obesity. Nat Rev Neurosci (2003) 4(11):901-909. Review providing an overview and update on current and past theories regarding fuel sensing and energy storage. The authors suggest that metabolic diseases occur from an altered sensing of stored fuels and ongoing fuel availability, or a combination of both.
48. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, Barsh GS, Watson SJ: Anatomy of an endogenous antagonist: Relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci (1999) 19(18):RC26.
49. Grill HJ, Kaplan JM: The neuroanatomical axis for control of energy balance. Front Neuroendocrinol (2002) 23(1):2-40. Review of the neuroanatomical basis of feeding behavior and energy expenditure. Previous reviews focused mainly on the control of the brain stem by hypothalamic centers, and not enough on the importance of sensory inputs from the brain stem to the hypothalamus relevant to energy balance.
50. Kilduff TS, Peyron C: The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders. Trends Neurosci (2000) 23(8):359-365.
51. Rodriguez M, Beauverger P, Naime I, Rique H, Ouvry C, Souchaud S, Dromaint S, Nagel N, Suply T, Audinot V, Boulin JA et al: Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol Pharmacol (2001) 60(4):632-639.
52. Mori M, Harada M, Terao Y, Sugo T, Watanabe T, Shimomura Y, Abe M, Shintani Y, Onda H, Nishimura O, Fujino M: Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem Biophys Res Commun (2001) 283(5):1013-1018.
53. Hill J, Duckworth M, Murdock P, Rennie G, Sabido-David C, Ames RS, Szekeres P, Wilson S, Bergsma DJ, Gloger IS, Levy DS et al: Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J Biol Chem (2001) 276(23):20125-20129.
54. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, Austin CP, Figueroa D, MacNeil D, Cascieri MA, Nargund R et al: Receptor for motilin identified in the human gastrointestinal system. Science (1999) 284(5423):2184-2188.
55. Dass NB, Hill J, Muir A, Testa T, Wise A, Sanger GJ: The rabbit motilin receptor: Molecular characterisation and pharmacology. Br J Pharmacol (2003) 140(5):948-954.
56. Lee DK, Nguyen T, Porter CA, Cheng R, George SR, O'Dowd BF: Two related G protein-coupled receptors: The distribution of GPR7 in rat brain and the absence of GPR8 in rodents. Brain Res Mol Brain Res (1999) 71(1):96-103.
57. Karasinska JM, George SR, O'Dowd BF: Family 1 G protein-coupled receptor function in the CNS. Insights from gene knockout mice. Brain Res Brain Res Rev (2003) 41(2-3):125-152.
58. Beck B: KO's and organisation of peptidergic feeding behavior mechanisms. Neurosci Biobehav Rev (2001) 25(2):143-158.
59. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD: A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology (2000) 141(9):3518-3521.
60. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM et al: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet (2000) 26(1):97-102.
61. Kobayashi S, Ohta M, Miyasaka K, Funakoshi A: Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats. Neurosci Lett (1996) 214(1):61-64.
62. Miyasaka K, Kanai S, Ohta M, Kawanami T, Kono A, Funakoshi A: Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene. Neurosci Lett (1994) 180(2):143-146.
63. Ishii M, Fei H, Friedman JM: Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci USA (2003) 100(18):10540-10545. This paper, along with references [64•], [65•], [66•], [67•], [68•], [69•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
64. Gu W, Geddes BJ, Zhang C, Foley KP, Stricker-Krongrad A: The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice. J Mol Neurosci (2004) 22(1-2):93-103. This paper, along with references [63•], [65•], [66•], [67•], [68•], [69•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
65. Mondal MS, Yamaguchi H, Date Y, Shimbara T, Toshinai K, Shimomura Y, Mori M, Nakazato M: A role for neuropeptide W in the regulation of feeding behavior. Endocrinology (2003) 144(11):4729-4733. This paper, along with references [63•], [64•], [66•], [67•], [68•], [69•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
66. Shimomura Y, Harada M, Goto M, Sugo T, Matsumoto Y, Abe M, Watanabe T, Asami Y, Kitada C, Mori M, Onda H et al: Identification of neuropeptide W as the endogenous ligand for orphan G protein-coupled receptors GPR7 and GPR8. J Biol Chem (2002) 277(39):35826-35832. This paper, along with references [63•], [64•], [65•], [67•], [68•], [69•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
67. Tanaka H, Yoshida T, Miyamoto N, Motoike T, Kurosu H, Shibata K, Yamanaka A, Williams SC, Richardson JA, Tsujino N, Garry MG et al: Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc Natl Acad Sci USA (2003) 100(10):6251-6256. This paper, along with references [63•], [64•], [65•], [66•], [68•], [69•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
68. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Fujino M, Inoue K: Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology (2001) 142(5):2032-2038. This paper, along with references [63•], [64•], [65•], [66•], [67•], [69•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
69. Samson WK, Resch ZT, Murphy TC: A novel action of the newly described prolactin-releasing peptides: Cardiovascular regulation. Brain Res (2000) 858(1):19-25. This paper, along with references [63•], [64•], [65•], [66•], [67•], [68•], [70•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
70. Zhang SQ, Kimura M, Inoue S: Effects of prolactin-releasing peptide (PrRP) on sleep regulation in rats. Psychiatry Clin Neurosci (2000) 54(3):262-264. This paper, along with references [63•], [64•], [65•], [66•], [67•], [68•], [69•] and [71•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
71. Bhattacharyya S, Luan J, Challis B, Schmitz C, Clarkson P, Franks PW, Middelberg R, Keogh J, Farooqi IS, Montague C, Brennand J et al: Association of polymorphisms in GPR10, the gene encoding the prolactin-releasing peptide receptor with blood pressure, but not obesity, in a UK caucasian population. Diabetes (2003) 52(5):1296-1299. This paper, along with references [63•], [64•], [65•], [66•], [67•], [68•], [69•] and [70•], discusses the implication of GPR7 and GPR10 in the regulation of food intake.
72. 2 receptors. Nature (1995) 377(6548):424-428.
73. 2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells (1996) 1(2):253-268.
74. 1A dopamine receptors. Proc Natl Acad Sci USA (1994) 91(26):12564-12568.
75. Contos JJ, Fukushima N, Weiner JA, Kaushal D, Chun J: Requirement for the IpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA (2000) 97(24):13384-13389.
76. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H: Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA (2002) 99(13):8938-8943.
77. Snyder EE, Walts B, Perusse L, Chagnon YC, Weisnagel SJ, Rankinen T, Bouchard C: The human obesity gene map: The 2003 update. Obes Res (2004) 12(3):369-439.
78. 2C receptor promoter polymorphism (HTR2C-759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet (2004) 126B(1):124-127.
79. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P: Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 106(2):253-262.
80. Santagata S, Boggon TJ, Baird CL, Gomez C, Zhao J, Shan WS, Myszka DG, Shapiro L: G protein-signaling through tubby proteins. Science (2001) 292(5524):2041-2050.
81. Spiegel AM, Weinstein LS: Inherited diseases involving G proteins and G protein-coupled receptors. Annu Rev Med (2004) 55:27-39.
82. Weinstein LS, Yu S, Warner DR, Liu J: Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr Rev (2001) 22(5):675-705.
83. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD et al: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 418(6898):650-654.
84. Halatchev IG, Ellacott KL, Fan W, Cone RD: Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology (2004) 145(6):2585-2590.
85. Hakak Y, Shrestha D, Goegel MC, Behan DP, Chalmers DT: Global analysis of G protein-coupled receptor signaling in human tissues. FEBS Lett (2003) 550(1-3):11-7.
86. Nitta H, Kishimoto J, Grogan TM: Application of automated mRNA in situ hybridization for formalin-fixed, paraffin-embedded mouse skin sections: Effects of heat and enzyme pretreatmsnt on mRNA signal detection. Appl Immunohistochem Mol Morphol (2003) 11(2):183-187.
87. Visel A, Thaller C, Eichele G: GenePaint.org: An atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res (2004) 32:D552-D556.
88. Lee DK, Lynch KR, Nguyen T, Im DS, Cheng R, Saldivia VR, Liu Y, Liu IS, Heng HH, Seeman P, George SR et al: Cloning and characterization of additional members of the G protein-coupled receptor family. Biochim Biophys Acta (2000) 1490(3):311-323.
89. Lee DK, George SR, Cheng R, Nguyen T, Liu Y, Brown M, Lynch KR, O'Dowd BF: Identification of four novel human G protein-coupled receptors expressed in the brain. Brain Res Mol Brain Res (2001) 86(1-2):13-22.
90. Brezillon S, Detheux M, Parmentier M, Hokfelt T, Hurd YL: Distribution of an orphan G protein-coupled receptor (JP05) mRNA in the human brain. Brain Res (2001) 921(1-2):21-30.
91. Wang D, Herman JP, Pritchard LM, Spitzer RH, Ahlbrand RL, Kramer GL, Petty F, Sallee FR, Richtand NM: Cloning, expression, and regulation of a glucocorticoid-induced receptor in rat brain: Effect of repetitive amphetamine. J Neurosci (2001) 21(22):9027-9035.
92. Tissir F, De-Backer O, Goffinet AM, Lambert de Rouvroit C: Developmental expression profiles of Celsr (Flamingo) genes in the mouse. Mech Dev (2002) 112(1-2):157-160.
93. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brezillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C et al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem (2001) 276(37):34631-34636.
94. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K et al: AXOR12: A novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 276(31):28969-28975.
95. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E: Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA (2003) 100(19):10972-10976.
96. Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, Yang S, Monsma FJ, Gustafson EL: The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun (2003) 312(4):1357-1363.
97. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Aciemo JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D et al: The GPR54 gene as a regulator of puberty. Obstet Gynecol Surv (2004) 59(5):351-353.
98. Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS, Lowell BB: Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem (1995) 270(49):29483-29492.
99. Ladenheim EE, Hampton LL, Whitney AC, White WO, Battey JF, Moran TH: Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice. J Endocrinol (2002) 174(2):273-281.
100. Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, Maeno H, Imaki J, Kikuyama S, Wada E, Wada K: Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature (1997) 390(6656):165-169.
101. Miyasaka K, Ichikawa M, Ohta M, Kanai S, Yoshida Y, Masuda M, Nagata A, Matsui T, Noda T, Takiguchi S, Takata Y et al: Energy metabolism and turnover are increased in mice lacking the cholecystokinin-B receptor. J Nutr (2002) 132(4):739-741.
102. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR: Estrogen deficiency, obesity and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology (2000) 141(11):4295-4308.
103. 1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol (2001) 281(5):R1442-R1448.
104. 3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest (2002) 110(12):1791-1799.
105. 3 receptors. Mol Pharmacol (2002) 62(2):389-397.
106. 2C serotonin receptors. Nature (1995) 374(6522):542-546.
107. Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M, Nakamura M: Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA (1998) 95(26):15659-15664.
108. Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, Beermann F, Brunner HR: Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med (1998) 4(6):722-726.
109. Naveilhan P, Hassani H, Canals JM, Ekstrand AJ, Larefalk A, Chhajlani V, Arenas E, Gedda K, Svensson L, Thoren P, Ernfors P: Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med (1999) 5(10):1188-1193.
110. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD: Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med (1998) 4(6):718-721.
111. Remaury A, Vita N, Gendreau S, Jung M, Arnone M, Poncelet M, Culouscou JM, Le Fur G, Soubrie P, Caput D, Shire D et al: Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Res (2002) 953(1-2):63-72.
112. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM: Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA (1998) 95(26):15496-15501.
113. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G: Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 410(6830):822-825.
114. 1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord (2004) 28(4):640-648.
115. 3 muscarinic acetylcholine receptor are hypophagic and lean. Nature (2001) 410(6825):207-212.
116. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 79(4):729-742.
117. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, Guan XM, Jiang MM, Feng Y, Camacho RE, Shen Z et al: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA (2002) 99(5):3240-3245.
118. Chen Y, Hu C, Hsu CK, Zhang Q, Bi C, Asnicar M, Hsiung HM, Fox N, Slieker LJ, Yang DD, Heiman ML et al: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 143(7):2469-2477.
119. Butler AA, Cone RD: Knockout models resulting in the development of obesity. Trends Genet (2001) 17(10):S50-S54.
120. Hotta M, Shibasaki T, Arai K, Demura H: Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res (1999) 823(1-2):221-225.
121. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF: Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 273(5281):1561-1564.
122. Chance WT, Balasubramaniam A, Stallion A, Fischer JE: Anorexia following the systemic injection of amylin. Brain Res (1993) 607(1-2):185-188.
123. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP et al: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 379(6560):69-72.
124. Danho W, Makofske RC, Swistok J, Michalewsky J, Gabriel T, Marks N, Berg MJ, Baird L, Geiler V, Mackie G et al: Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors. Pept Res (1991) 4(2):59-65.
125. Lawrence CB, Ellacott KL, Luckman SM: PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology (2002) 143(2):360-367.
126. 2C receptor agonist and D-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl) (2000) 152(3):256-267.
127. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL: Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci (1998) 63(8):PL113-PL117.
128. 3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats. Biol Psychiatry (1999) 45(4):475-481.
129. Kask A, Rago L, Harro J: Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: Studies with Y1-selective antagonist BIBP3226. Br J Pharmacol (1998) 124(7):1507-1515.
130. Kask A, Vasar E, Heidmets LT, Allikmets L, Wikberg JE: Neuropeptide Y Y(5) receptor antagonist CGP71683A: The effects on food intake and anxiety-related behavior in the rat. Eur J Pharmacol (2001) 414(2-3):215-224.
131. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos FE: A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (1996) 380(6571):243-247.
132. Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ: Opioids and consummatory behavior. Brain Res Bull (1985) 14(6):663-672.
133. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature (2000) 407(6806):908-913.
134. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR: Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 92(4):573-585.